EPIEN Medical

EPIEN Medical, founded in 2014 and headquartered in Minneapolis, Minnesota, is a private biotechnology company commercializing a unique chemical desiccation technology for tissue debridement. Its flagship platform, Desiccation Shock Technology (DST), provides a rapid, non-antibiotic method to cleanse wounds by removing necrotic tissue and biofilm, resetting the wound bed for natural healing. The company has commercial products in dental/oral care and is developing applications in chronic wound care, veterinary medicine, and dermatology, positioning itself in the large and growing advanced wound management market.

Desiccation Shock Technology (DST) / Desiccation Shock Debridement (DSD) - a proprietary chemical process that rapidly desiccates and mechanically removes necrotic tissue and microbial biofilm from wound beds in under 60 seconds without harming healthy tissue.

EPIEN competes in wound debridement against established surgical tools, enzymatic debriders (e.g., Santyl), autolytic dressings, and other mechanical methods. Its differentiation lies in the speed and chemical/physical mechanism of action targeting biofilm. In dental care, it competes with various topical analgesics and antimicrobial rinses.